Pages

Monday, November 18, 2019

Pharma Reviews: Glenmark Pharma jumps 21% on CLSA upgrade

NEW DELHI: Shares of Glenmark Pharmaceuticals rallied over 21 per cent ... to remain strong whereas India should continue growing above the industry rate. ... The drug firm last week reported a consolidated net profit to Rs 255.54 ...
Read more: Glenmark Pharma jumps 21% on CLSA upgrade